학술논문

AlphaBet: A phase I/II trial evaluating the combination of radium-223 and [177Lu]Lu-PSMAI&T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 20 2023, 41 1p. Supplement: 6
Subject
Language
English
ISSN
15277755